Guardant Health (NASDAQ:GH) announced robust first-quarter 2026 results, reporting a 48% increase in revenue to $302 million. The significant growth was driven by strong performance across its key business segments.
Guardant Health Reports Strong Q1 2026 Revenue Growth
earningsbiotechhealthcarerevenue_growthQ1_2026

